Clearside Biomedical Inc (CLSD)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
Clearside Biomedical Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.1131 |
September 30, 2020 | 0.122 |
June 30, 2020 | 0.136 |
March 31, 2020 | 0.4965 |
Date | Value |
---|---|
December 31, 2019 | 0.4618 |
September 30, 2019 | 1.041 |
June 30, 2019 | 0.7828 |
March 31, 2019 | 0.6237 |
December 31, 2018 | 0.4223 |
September 30, 2018 | 0.2248 |
June 30, 2018 | 0.1477 |
March 31, 2018 | 0.085 |
December 31, 2017 | 0.374 |
September 30, 2017 | 0.2142 |
June 30, 2017 | 0.1435 |
March 31, 2017 | 0.1145 |
December 31, 2016 | 0.1059 |
September 30, 2016 | 0.1596 |
June 30, 2016 | 0.1239 |
March 31, 2016 | 1.104 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2021
1.041
Maximum
Sep 2019
0.166
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
Cassava Sciences Inc | -- |
Heron Therapeutics Inc | -5.114 |
Actinium Pharmaceuticals Inc | -- |
Karyopharm Therapeutics Inc | -1.255 |
Ocular Therapeutix Inc | 0.8222 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 34.02M |
Total Liabilities (Quarterly) | 49.93M |
Shareholders Equity (Quarterly) | -15.91M |
Current Ratio | 4.421 |